Medical diagnostic tests developer Inova Diagnostics has introduced a rapid-response chemiluminescent analyser with Quanta Flash reagents for autoimmune disease diagnostic testing.
The Bio-Flash analyser, which uses chemiluminescent technology, is designed for use in clinical reference and hospital laboratories to provide full automation of a broad menu of highly accurate Quanta Flash immunoassays for autoimmunity testing.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Bio-Flash and the Quanta Flash reagents, which are classified as moderately complex under the Clinical Laboratories Improvements Act (CLIA), generate first result in as little as 30 minutes, with additional results produced at a rate of one-per-minute thereafter.
The analyser also offers other benefits including an increased analytical measuring range, onboard dilution and stored calibration.
A comprehensive menu of Quanta Flash reagents is also available, including tests to aid in the diagnosis of celiac disease, vasculitis, antiphospholipid syndrome and connective tissue diseases, according to the company.
Alberta Research and Innovation Authority chairman and University of Calgary professor of medicine and Arthritis Society Research chair Dr Marvin Fritzler said Bio-Flash has dramatically enhanced the workflow and decreased turnaround times for autoantibody testing at his laboratory.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData"The user-friendly interface allows rapid adoption by laboratory staff members," Fritzler said.
"We are looking forward to an expanding catalogue of immunoassays developed by INOVA."
